Quantum Financial Advisors LLC Buys 163 Shares of Colgate-Palmolive (NYSE:CL)

Quantum Financial Advisors LLC increased its stake in Colgate-Palmolive (NYSE:CL) by 6.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,526 shares of the company’s stock after purchasing an additional 163 shares during the period. Quantum Financial Advisors LLC’s holdings in Colgate-Palmolive were worth $230,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of CL. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 3rd quarter worth $42,000. Capital Performance Advisors LLP acquired a new position in Colgate-Palmolive during the third quarter worth about $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive in the third quarter worth about $64,000. True Wealth Design LLC boosted its stake in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after purchasing an additional 672 shares in the last quarter. Finally, Continuum Advisory LLC grew its holdings in shares of Colgate-Palmolive by 93.4% during the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock valued at $79,000 after purchasing an additional 368 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Stock Up 0.8 %

Shares of NYSE:CL opened at $87.02 on Tuesday. The business’s 50 day moving average is $92.49 and its 200 day moving average is $97.98. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The stock has a market cap of $71.10 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 3.31 and a beta of 0.44. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.30%. Colgate-Palmolive’s payout ratio is 57.31%.

Analyst Ratings Changes

Several brokerages recently commented on CL. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price objective for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Piper Sandler lowered their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, JPMorgan Chase & Co. boosted their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and a consensus price target of $103.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.